TL;DR
This study reveals that neutrophils, specifically those found in the stromal regions of bladder tumors, are associated with poorer patient survival in urothelial carcinoma of the bladder (UCB). These neutrophils appear to suppress the anti-tumor immune response by inhibiting T cell activity and promoting T cell apoptosis, partly through the PD-L1 pathway.
What Problem Does This Paper Address?
Urothelial carcinoma of the bladder (UCB) is a significant cancer, and while advancements in immunotherapy have improved outcomes for some, many patients still don't respond effectively. A key factor in this resistance is the tumor microenvironment (TME), which can be immunosuppressive. While T cells are known to play a role in anti-tumor immunity, the specific contribution of neutrophils, which are abundant in the TME, has been unclear. This paper aims to clarify the clinical significance and functional role of neutrophils in UCB, particularly their interaction with T cells and their impact on patient survival.
Methods
The researchers employed a multi-pronged approach:
- Immunohistochemistry (IHC) and Immunofluorescence (IF): They analyzed UCB tissue samples from a cohort of 237 patients to quantify the presence and location of CD66b+ neutrophils, as well as CD4+ and CD8+ T cells, and apoptosis markers (Cleaved Caspase-3). This allowed them to assess the spatial distribution of these cells and their correlation with clinical outcomes.
- Flow Cytometry: This technique was used to analyze the phenotype of neutrophils isolated from UCB tissues and peripheral blood. It was also crucial for assessing T cell proliferation, activation (measured by IFN-γ production), and apoptosis in co-culture experiments.
- In Vitro Co-culture System: Peripheral blood neutrophils (PBNs) and tumor supernatant-treated neutrophils (TTNs), designed to mimic tumor-associated neutrophils (TANs), were co-cultured with T cells from healthy donors. This allowed for direct investigation of how neutrophils affect T cell function.
- Bio-Plex Multiplex Immunoassays: Used to identify cytokines secreted by bladder cancer cell lines, specifically focusing on potential inducers of PD-L1 expression on neutrophils.
- TCGA Data Analysis: Publicly available The Cancer Genome Atlas (TCGA) data was analyzed to correlate gene expression of cytokines with PD-L1 expression in bladder tumors.
Datasets
- UCB Patient Samples: Two cohorts of UCB patients were used:
- Group 1: 237 patients with FFPE (formalin-fixed paraffin-embedded) samples for survival analysis, stratified by tumor stage and grade.
- Group 2: 57 patients with FFPE samples for evaluating neutrophil and T cell markers.
- The Cancer Genome Atlas (TCGA): Data from 408 bladder cancer patients was utilized to analyze correlations between gene expression and clinical outcomes.
Key Insights and Ideas
- Stromal Neutrophils as a Poor Prognostic Marker: The density of CD66b+ neutrophils in the stromal (ST) regions of UCB tumors, but not the intratumoral (INT) regions, emerged as a significant independent predictor of poor overall survival. This highlights the importance of cell location within the tumor microenvironment.
- Neutrophil-T Cell Crosstalk: High infiltration of stromal neutrophils was found to diminish the otherwise beneficial prognostic impact of CD4+ and CD8+ T cell infiltration. This suggests a direct antagonistic relationship.
- Neutrophils Suppress T Cell Immunity: In vitro experiments demonstrated that tumor-conditioned neutrophils (TTNs) significantly inhibited T cell proliferation and activation, and promoted T cell apoptosis.
- PD-L1 as a Key Mediator: Tumor-conditioned neutrophils (TTNs) showed increased expression of PD-L1, and blocking PD-L1 partially reversed their immunosuppressive effects on T cells. This points to the PD-1/PD-L1 axis as a crucial mechanism.
- GM-CSF Drives PD-L1 Expression: Tumor cell supernatants contained GM-CSF, which was identified as a key factor inducing PD-L1 expression on neutrophils.
Key Results
- Prognostic Significance: Higher stromal CD66b+ neutrophil density was significantly associated with shorter overall survival (P = 0.006) and positively correlated with age, tumor stage, nodal metastasis, and histological grade.
- Co-localization: Stromal CD66b+ neutrophils were frequently found alongside CD4+ T cells (R=0.35, P=0.0067), CD8+ T cells (R=0.52, P<0.0001), and apoptosis markers (R=0.44, P=0.0007).
- T Cell Suppression: TTNs significantly inhibited CD4+ and CD8+ T cell proliferation (Figures 3A, B), reduced IFN-γ production (Figures 3C, D), and increased apoptosis (Figures 3E, F) compared to control PBNs.
- PD-L1 Upregulation: TTNs showed markedly upregulated PD-L1 expression compared to PBNs (Figure 4A, B). Blocking PD-L1 with an antibody partially restored T cell proliferation and activation, and reduced apoptosis (Figures 4E, F, G).
- GM-CSF Induction: Neutralizing GM-CSF in the co-culture system significantly blocked PD-L1 expression on TTNs (Figure 5D, E).
Limitations and Future Work
- Limitations:
- The study acknowledges a limited number of matched tissues from patients who progressed from non-muscle-invasive bladder cancer (NMIBC) to muscle-invasive bladder cancer (MIBC), restricting longitudinal studies on tumor progression.
- The functional study used TTNs to mimic TANs, and while they share similar phenotypes, direct investigation of TAN/T cell crosstalk in situ warrants further study.
- The study focused on treatment-naïve UCB patients, so comparisons with patients treated with BCG, chemotherapy, or radiotherapy are not possible.
- Future Work:
- The authors suggest that the value of neutrophils in predicting the outcome of immune checkpoint inhibitors (ICIs) for advanced MIBC needs further investigation.
- Further research is needed to fully elucidate the mechanisms of TAN-induced immunosuppression.
- The study highlights the importance of the PD-L1/PD-1 pathway in tumor-related immunosuppression in UCB.
Summary updated